Document And Entity Information
Document And Entity Information - shares | 9 Months Ended | |
Sep. 30, 2020 | Nov. 12, 2020 | |
Document Information [Line Items] | ||
Entity Registrant Name | CurAegis Technologies, Inc. | |
Entity Central Index Key | 0001063197 | |
Current Fiscal Year End Date | --12-31 | |
Entity Filer Category | Non-accelerated Filer | |
Entity Current Reporting Status | Yes | |
Entity Emerging Growth Company | false | |
Entity Small Business | true | |
Entity Interactive Data Current | Yes | |
Entity Common Stock, Shares Outstanding (in shares) | 51,452,810 | |
Entity Shell Company | false | |
Document Type | 10-Q | |
Document Period End Date | Sep. 30, 2020 | |
Document Fiscal Year Focus | 2020 | |
Document Fiscal Period Focus | Q3 | |
Amendment Flag | false |
Condensed Consolidated Balance
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($) | Sep. 30, 2020 | Dec. 31, 2019 |
Current Assets: | ||
Cash | $ 87,000 | $ 18,000 |
Prepaid expenses | 12,000 | 2,000 |
Total current assets | 99,000 | 20,000 |
Right to use asset (net) | 156,000 | 193,000 |
Property and equipment (net) | 29,000 | 38,000 |
Total non-current assets | 185,000 | 231,000 |
Total Assets | 284,000 | 251,000 |
Current Liabilities: | ||
Liability for inventory | 1,740,000 | 1,764,000 |
Demand notes | 650,000 | 650,000 |
Promissory notes | 425,000 | 425,000 |
Accounts payable | 366,000 | 420,000 |
Accrued interest | 877,000 | 509,000 |
Current right-to-use obligation | 67,000 | 64,000 |
Other current liabilities | 20,000 | 36,000 |
Accrued wages and benefits | 58,000 | 50,000 |
Total current liabilities | 4,203,000 | 3,918,000 |
Non-current right-to-use obligation | 83,000 | 126,000 |
PPP loan | 228,000 | |
Senior convertible notes (net) | 9,992,000 | 8,410,000 |
Total Liabilities | 14,506,000 | 12,454,000 |
Commitments and other matters | ||
Stockholders' Deficiency: | ||
Common stock, $.01 par value, 400,000,000 shares authorized; shares issued and outstanding at September 30, 2020 and December 31, 2019: 51,452,810 and 50,979,964 respectively | 515,000 | 510,000 |
Additional paid-in capital | 77,695,000 | 78,272,000 |
Accumulated deficit | (92,872,000) | (91,425,000) |
Total Stockholders' Deficiency | (14,222,000) | (12,203,000) |
Total Liabilities and Stockholders' Deficiency | 284,000 | 251,000 |
Preferred Class C [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 157,000 | 157,000 |
Series C2 Preferred Stock [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 245,000 | 245,000 |
Series C3 Preferred Stock [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 32,000 | 32,000 |
Preferred Class A [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | 5,000 | 5,000 |
Preferred Class B [Member] | ||
Stockholders' Deficiency: | ||
Preferred stock, value | $ 1,000 | $ 1,000 |
Condensed Consolidated Balanc_2
Condensed Consolidated Balance Sheets (Current Period Unaudited) (Parentheticals) - $ / shares | Sep. 30, 2020 | Dec. 31, 2019 |
Preferred stock, shares authorized (in shares) | 100,000,000 | 100,000,000 |
Preferred stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 |
Common stock, shares authorized (in shares) | 400,000,000 | 400,000,000 |
Common stock, shares issued (in shares) | 51,452,810 | 50,979,964 |
Common stock, shares outstanding (in shares) | 51,452,810 | 50,979,964 |
Preferred Class C [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 15,687,500 | 15,687,500 |
Preferred stock, shares outstanding (in shares) | 15,687,500 | 15,687,500 |
Series C2 Preferred Stock [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 24,500,000 | 24,500,000 |
Preferred stock, shares outstanding (in shares) | 24,500,000 | 24,500,000 |
Series C3 Preferred Stock [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0 | $ 0 |
Preferred stock, shares issued (in shares) | 3,238,000 | 3,238,000 |
Preferred stock, shares outstanding (in shares) | 3,238,000 | 3,238,000 |
Preferred Class A [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0.40 | $ 0.40 |
Preferred stock, shares issued (in shares) | 468,221 | 468,221 |
Preferred stock, shares outstanding (in shares) | 468,221 | 468,221 |
Preferred Class B [Member] | ||
Preferred stock, cumulative dividend per share (in dollars per share) | $ 0.50 | $ 0.50 |
Preferred stock, shares issued (in shares) | 67,500 | 67,500 |
Preferred stock, shares outstanding (in shares) | 67,500 | 67,500 |
Condensed Consolidated Statemen
Condensed Consolidated Statements of Operations (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Revenue and Cost of revenue: | ||||
CURA revenue | $ 2,000 | $ 4,000 | $ 7,000 | $ 13,000 |
Cost of revenue | 2,000 | 2,000 | 15,000 | 11,000 |
Gross Profit (Loss) | 2,000 | (8,000) | 2,000 | |
Costs and expenses: | ||||
Recovery on inventory reserve | (74,000) | (13,000) | (97,000) | (13,000) |
Engineering and development | 98,000 | 178,000 | 254,000 | 727,000 |
General and administrative (recovery) | (456,000) | 339,000 | 200,000 | 1,326,000 |
Total costs and expenses (income) | (432,000) | 504,000 | 357,000 | 2,040,000 |
Income (Loss) from operations | 432,000 | (502,000) | (365,000) | (2,038,000) |
Other (expense) income | 47,000 | 9,000 | (52,000) | 10,000 |
Non-operating expense: | ||||
Interest expense | (352,000) | (320,000) | (1,030,000) | (898,000) |
Debt issuance cost | (304,000) | (304,000) | ||
Vendor penalty | (300,000) | (300,000) | ||
Non-operating expense | (305,000) | (915,000) | (1,082,000) | (1,492,000) |
Income (Loss) before income taxes | 127,000 | (1,417,000) | (1,447,000) | (3,530,000) |
Income taxes | ||||
Net Income (Loss) | 127,000 | (1,417,000) | (1,447,000) | (3,530,000) |
Preferred stock dividends | 54,000 | 55,000 | 163,000 | 163,000 |
Net loss attributable to common stockholders | $ 73,000 | $ (1,472,000) | $ (1,610,000) | $ (3,693,000) |
Net loss per common share attributable to common stockholders | ||||
Basic and Diluted (in dollars per share) | $ 0 | $ (0.03) | $ (0.03) | $ (0.07) |
Weighted average number of shares of common stock | ||||
Basic and Diluted (in shares) | 51,447,000 | 50,776,000 | 51,325,000 | 50,565,000 |
Condensed Consolidated Statem_2
Condensed Consolidated Statement of Changes in Stockholders' Deficiency (Unaudited) - USD ($) | 3 Months Ended | 9 Months Ended | ||||||
Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Preferred Stock [Member] | Series C Preferred Stock [Member] | ||||||||
Balance (in shares) | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 |
Balance | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | ||||||||
Common shares issued for interest | ||||||||
Common shares issued (in shares) | ||||||||
Common shares issued | ||||||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 | 15,687,500 |
Balance | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 | $ 157,000 |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes (in shares) | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Preferred Stock [Member] | Series C2 Preferred Stock [Member] | ||||||||
Balance (in shares) | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 |
Balance | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | ||||||||
Common shares issued for interest | ||||||||
Common shares issued (in shares) | ||||||||
Common shares issued | ||||||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 | 24,500,000 |
Balance | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 | $ 245,000 |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes (in shares) | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Preferred Stock [Member] | Series C3 Preferred Stock [Member] | ||||||||
Balance (in shares) | 3,238,000 | 3,238,000 | 3,238,000 | 3,268,000 | 3,268,000 | 3,268,000 | 3,238,000 | 3,268,000 |
Balance | $ 32,000 | $ 32,000 | $ 32,000 | $ 33,000 | $ 33,000 | $ 33,000 | $ 32,000 | $ 33,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | ||||||||
Common shares issued for interest | ||||||||
Common shares issued (in shares) | ||||||||
Common shares issued | ||||||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 3,238,000 | 3,238,000 | 3,238,000 | 3,268,000 | 3,268,000 | 3,268,000 | 3,238,000 | 3,268,000 |
Balance | $ 32,000 | $ 32,000 | $ 32,000 | $ 33,000 | $ 33,000 | $ 33,000 | $ 32,000 | $ 33,000 |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes (in shares) | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Preferred Stock [Member] | Preferred Class A [Member] | ||||||||
Balance (in shares) | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 |
Balance | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | ||||||||
Common shares issued for interest | ||||||||
Common shares issued (in shares) | ||||||||
Common shares issued | ||||||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 | 468,221 |
Balance | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 | $ 5,000 |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes (in shares) | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Preferred Stock [Member] | Preferred Class B [Member] | ||||||||
Balance (in shares) | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 |
Balance | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | ||||||||
Common shares issued for interest | ||||||||
Common shares issued (in shares) | ||||||||
Common shares issued | ||||||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 | 67,500 |
Balance | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes (in shares) | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Common Stock [Member] | ||||||||
Balance (in shares) | 51,415,310 | 51,187,236 | 50,979,964 | 50,529,701 | 50,400,545 | 50,364,549 | 50,979,964 | 50,364,549 |
Balance | $ 514,000 | $ 512,000 | $ 510,000 | $ 505,000 | $ 504,000 | $ 504,000 | $ 510,000 | $ 504,000 |
Stock-based compensation | ||||||||
Common shares issued for interest (in shares) | 123,074 | 94,772 | 33,973 | 39,156 | 35,996 | |||
Common shares issued for interest | $ 1,000 | $ 1,000 | $ 1,000 | |||||
Common shares issued (in shares) | 37,500 | 105,000 | 112,500 | 90,000 | ||||
Common shares issued | $ 1,000 | $ 1,000 | $ 1,000 | $ 1,000 | ||||
Net Income (loss) | ||||||||
Stock-based compensation | ||||||||
Balance (in shares) | 51,452,810 | 51,415,310 | 51,187,236 | 50,803,674 | 50,529,701 | 50,400,545 | 51,452,810 | 50,803,674 |
Balance | $ 515,000 | $ 514,000 | $ 512,000 | $ 508,000 | $ 505,000 | $ 504,000 | $ 515,000 | $ 508,000 |
Warrants issued with convertible note | ||||||||
Common shares issued upon note conversions (in shares) | 75,000 | |||||||
Common shares issued upon note conversions | $ 1,000 | |||||||
Common shares issued with demand notes (in shares) | 165,000 | |||||||
Common shares issued with demand notes | $ 1,000 | |||||||
Share rights issued with demand notes | ||||||||
Additional Paid-in Capital [Member] | ||||||||
Balance | 78,337,000 | 78,336,000 | 78,272,000 | 77,923,000 | 77,855,000 | 77,725,000 | 78,272,000 | 77,725,000 |
Stock-based compensation | (645,000) | (28,000) | 39,000 | 7,000 | 45,000 | 59,000 | ||
Common shares issued for interest | 20,000 | 16,000 | 8,000 | 10,000 | 8,000 | |||
Common shares issued | 3,000 | 9,000 | 9,000 | 11,000 | ||||
Net Income (loss) | ||||||||
Stock-based compensation | (645,000) | (28,000) | 39,000 | 7,000 | 45,000 | 59,000 | ||
Balance | 77,695,000 | 78,337,000 | 78,336,000 | 78,210,000 | 77,923,000 | 77,855,000 | 77,695,000 | 78,210,000 |
Warrants issued with convertible note | 2,000 | 63,000 | ||||||
Common shares issued upon note conversions | 6,000 | |||||||
Common shares issued with demand notes | 16,000 | |||||||
Share rights issued with demand notes | 250,000 | |||||||
Retained Earnings [Member] | ||||||||
Balance | (92,999,000) | (92,178,000) | (91,425,000) | (89,262,000) | (88,297,000) | (87,149,000) | (91,425,000) | (87,149,000) |
Stock-based compensation | ||||||||
Common shares issued for interest | ||||||||
Common shares issued | ||||||||
Net Income (loss) | 127,000 | (821,000) | (753,000) | (1,417,000) | (965,000) | (1,148,000) | ||
Stock-based compensation | ||||||||
Balance | (92,872,000) | (92,999,000) | (92,178,000) | (90,679,000) | (89,262,000) | (88,297,000) | (92,872,000) | (90,679,000) |
Warrants issued with convertible note | ||||||||
Common shares issued with demand notes | ||||||||
Share rights issued with demand notes | ||||||||
Balance | (13,708,000) | (12,890,000) | (12,203,000) | (10,393,000) | (9,497,000) | (8,479,000) | (12,203,000) | (8,479,000) |
Stock-based compensation | (645,000) | (28,000) | 39,000 | 7,000 | 45,000 | 59,000 | ||
Common shares issued for interest | 21,000 | 17,000 | 9,000 | 10,000 | 8,000 | |||
Common shares issued | 4,000 | 10,000 | 10,000 | 12,000 | ||||
Net Income (loss) | 127,000 | (821,000) | (753,000) | (1,417,000) | (965,000) | (1,148,000) | (1,447,000) | (3,530,000) |
Stock-based compensation | (645,000) | (28,000) | 39,000 | 7,000 | 45,000 | 59,000 | ||
Balance | $ (14,222,000) | $ (13,708,000) | $ (12,890,000) | (11,520,000) | (10,393,000) | (9,497,000) | $ (14,222,000) | $ (11,520,000) |
Warrants issued with convertible note | $ 2,000 | $ 63,000 | ||||||
Common shares issued upon note conversions | 7,000 | |||||||
Common shares issued with demand notes | 17,000 | |||||||
Share rights issued with demand notes | $ 250,000 |
Condensed Consolidated Statem_3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($) | 9 Months Ended | |
Sep. 30, 2020 | Sep. 30, 2019 | |
Cash flows from operating activities: | ||
Net loss | $ (1,447,000) | $ (3,530,000) |
Adjustments to reconcile net loss to net cash used in operating activities: | ||
Amortization of debt discount reported as interest | 607,000 | 546,000 |
Depreciation and amortization | 46,000 | 109,000 |
Fair market value of share rights issued with demand notes | 250,000 | |
Stock-based compensation | (634,000) | 111,000 |
Interest paid in shares | 38,000 | 27,000 |
Changes in working capital items: | ||
Prepaid expenses | (10,000) | 22,000 |
Liability for inventory | (24,000) | 315,000 |
Accounts payable | (57,000) | 73,000 |
Accrued interest | 330,000 | 210,000 |
Other current liabilities | (16,000) | 35,000 |
Accrued wages and benefits | 8,000 | 14,000 |
Net cash used in operating activities | (1,159,000) | (1,818,000) |
Cash flows from financing activities: | ||
Proceeds from issuance of senior convertible notes (net) | 1,000,000 | 825,000 |
Proceeds from demand notes | 550,000 | |
Proceeds from issuance of unsecured subordinated notes | 575,000 | |
Proceeds from PPP loan | 228,000 | |
Cash used in repayment of unsecured promissory notes | (150,000) | |
Net cash provided by financing activities | 1,228,000 | 1,800,000 |
Net increase (decrease) in cash | 69,000 | (18,000) |
Cash at beginning of period | 18,000 | 53,000 |
Cash at end of period | 87,000 | 35,000 |
Supplemental Disclosures: | ||
Cash used for payment of interest expense | 19,000 | 86,000 |
Debt discount related to issuance of convertible notes | 24,000 | 65,000 |
Common shares issued in payment of interest expense | 38,000 | |
Right to use asset | $ 156,000 | $ 212,000 |
Note 1 - The Company and Basis
Note 1 - The Company and Basis of Presentation | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] | NOTE 1 CurAegis Technologies, Inc. (“CurAegis”, “the Company”) was incorporated as a New York business corporation in September 1996 2016 two The Company is focused on the commercialization of a wellness and safety system (the CURA System) and a uniquely designed hydraulic pump that will be smaller, lighter, less expensive and more efficient than current technology. The Company has not The Company has created the CURA app to offer products that reduce fatigue risk in the workplace and help individuals manage their sleep and improve alertness. The CURA System consists of a real-time alertness measurement and the Z-Coach wellness program. The Aegis hydraulic pump technology brings to the hydraulic industry a unique technology that is designed to be: smaller, lighter, less expensive, and more efficient than conventional pumps and motors. During 2019, April 8, 2020, 19 It is important to note that the cycle time from the initiation of the sales process to revenue realization can be highly variable especially as a start-up entity. In addition to the activities to be undertaken to implement our plan of operations, we may Current Cash Outlook and Management Plans As of September 30, 2020, $87,000, $4,104,000, $92,872,000 $14,222,000. nine September 30, 2020 $1,000,000 $235,000 Management estimates that the 2020 $1.7 $2 nine September 30, 2020. September 30, 2020, not Since inception, we have financed our operations by the sale of our securities and debt financings. We need to raise additional funds to meet our working capital needs, to fund expansion of our business, to complete development, testing and marketing of our products, or to make strategic acquisitions or investments. No may not The Company's ability to fund its current and future commitments from its available cash depends on its ability to launch and generate sales from the CURA app. If the Company cannot generate revenue from the CURA app, it would need to raise funds in order to meet its working capital needs and pursue its growth strategy. Although there can be no |
Note 2 - Summary of Significant
Note 2 - Summary of Significant Accounting Policies | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Significant Accounting Policies [Text Block] | NOTE 2 Basis of Presentation: 10 8 03 X not not December 31, 2019 2019 10 Consolidation: 56% September 30, 2020, Use of Estimates: Reclassifications: may Cash: may $5,000. Inventory September 30, 2020 December 31, 2019 Depreciation and amortization: three nine September 30, 2020 2019 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2020 2019 2020 2019 Right-to use building $ 17,000 $ 29,000 $ 37,000 $ 81,000 Software amortization - 2,000 - 8,000 Property and equipment 3,000 6,000 9,000 20,000 $ 20,000 $ 37,000 $ 46,000 $ 109,000 Right to use building asset: No. 2016 02, January 1, 2019. not no Software, Property and Equipment: 3 5 7 when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in non-operating income (expense). Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 September 30, 2020 December 31, 2019. $2,977,000 September 30, 2020 Revenue Recognition and Deferred Revenue: 606, The Company's revenue is derived primarily from domestic customers. For the three nine September 30, 2020 $2,000 7,000 100% three nine September 30, 2020. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the Company's performance of all obligations as described in customer agreements. The Z-Coach program provides fatigue training over an annual subscription period of twelve Engineering and Development: General and Administrative: three September 30, 2020 2019 $0 $14,000 nine September 30, 2020 2019 $17,000 $35,000 Stock-based Compensation: 718 10 718 10. No Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not September 30, 2020, December 31, 2019, no Loss per Common Share: 260 10 September 30, 2020 2019, 107,992,768 104,288,815 625,000 September 30, 2020 2019 not |
Note 3 - Inventory and Vendor L
Note 3 - Inventory and Vendor Liability | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Inventory Disclosure [Text Block] | NOTE 3 September 30, 2020 December 31, 2019 Raw materials $ 1,568,000 $ 1,665,000 Finished goods 69,000 69,000 1,637,000 1,734,000 Less: Reserve (1,637,000 ) (1,734,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,740,000 $ 1,764,000 During 2017, third During the nine September 30, 2020, $97,000 |
Note 4 - Demand Note
Note 4 - Demand Note | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Long-term Debt [Text Block] | NOTE 4 On July 23, 2019, $1,500,000 The co-borrowers participating in this credit facility received 30,000 $100,000 one one $0.15 five As of September 30, 2020, $650,000 195,000 $21,000 4,333,333 $0.15 $276,000 Advances drawn under this facility have been issued as demand notes with an adjustable interest rate set at the bank's prime rate, which was 3.25% September 30, 2020. $5,000 three September 30, 2020 September 30, 2019. $19,000 12,000 nine September 30, 2020 September 30, 2019, The common shares issued with these demand notes are being offered and sold in a private placement exempt from registration under Section 4 2 1933 506 not may not |
Note 5 - Paycheck Protection Pl
Note 5 - Paycheck Protection Plan Loan | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Long-term Debt [Text Block] | NOTE 4 On July 23, 2019, $1,500,000 The co-borrowers participating in this credit facility received 30,000 $100,000 one one $0.15 five As of September 30, 2020, $650,000 195,000 $21,000 4,333,333 $0.15 $276,000 Advances drawn under this facility have been issued as demand notes with an adjustable interest rate set at the bank's prime rate, which was 3.25% September 30, 2020. $5,000 three September 30, 2020 September 30, 2019. $19,000 12,000 nine September 30, 2020 September 30, 2019, The common shares issued with these demand notes are being offered and sold in a private placement exempt from registration under Section 4 2 1933 506 not may not |
Paycheck Protection Program CARES Act [Member] | |
Notes to Financial Statements | |
Long-term Debt [Text Block] | NOTE 5 On April 20, 2020 $228,000 eight 1% 6 18 |
Note 6 - Senior Convertible Not
Note 6 - Senior Convertible Notes | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Debt Disclosure [Text Block] | NOTE 6 At September 30, 2020, $11,310,000 $1,318,000, $9,992,000. December 31, 2019, $10,310,000 $1,901,000 $8,409,000. Scheduled maturities on the Company's convertible notes is as follows: $2,990,000 twelve December 31, 2021, $2,775,000 twelve December 31, 2022; $3,395,000 twelve December 31, 2023, $1,150,000 twelve December 31, 2024 $1,000,000 Included in the face value of convertible notes outstanding at September 30, 2020 December 31, 2019, $2,402,000 $2,477,000 $2,070,000 $1,170,000 September 30, 2020 December 31, 2019, Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2019 $ 10,310,000 $ 650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued 1,000,000 1,000,000 - - - - Face value September 30, 2020 $ 11,310,000 $ 1,650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2019 $ (1,901,000 ) $ (3,000 ) $ (354,000 ) $ (185,000 ) $ (362,000 ) $ (997,000 ) Debt discount issued (24,000 ) (24,000 ) - - - - Amortization reported as interest 607,000 21,000 62,000 36,000 83,000 405,000 Debt discount September 30, 2020 $ (1,318,000 ) $ (6,000 ) $ (292,000 ) $ (149,000 ) $ (279,000 ) $ (592,000 ) Senior Convertible Notes (net) $ 9,992,000 $ 1,644,000 $ 1,383,000 $ 476,000 $ 4,091,000 $ 2,398,000 2019 In April 2019, $2.5 6% “2019 May 28, 2019 “2019 2019 five five The conversion rate of the notes is fixed at the greater of: $0.15 30,000 $100,000 2019 4 2 1933 506 501 During the three nine September 30, 2020, $275,000 $1,000,000, $5,000 $24,000, three nine September 30, 2020, $32,000 $78,000 three nine September 30, 2019, $15,000 $19,000, JULY 2018 In July 2018, $2.5 “JULY 2018 July 24, 2018 “JULY 2018 JULY 2018 five April 2019, The conversion rate of the notes was fixed at $0.25 July 24, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three nine September 30, 2020 $21,000 $62,000 three nine September 30, 2019 $20,000 $52,000 2018 In May 2018, $1 “2018 May 8, 2018 “2018 2018 five July 19, 2018, The conversion rate of the notes was fixed at $0.25 May 8, 2018. 10% 25% $0.25 ten 4 2 1933 506 501 During the three nine September 30, 2020 $12,000 $36,000 three nine September 30, 2019 $11,000 $34,000 2017 The board of directors authorized the issuance of up to $5 6% “2017 May 31, 2017 “2017 2017 five 6%. 10% 25% The conversion rate of the 2017 $0.50 November 2018 $0.333 2017 November 2019 $0.333 2017 4 2 506 501 During the three nine September 30, 2020 $94,000 $279,000, three nine September 30, 2019 $92,000 $264,000, 2016 During 2016, $3 6% “2016 August 25, 2016 “2016 2016 five August 2021 December 2021 6%. The conversion rate of the notes was fixed at $0.25 August 25, 2016. 10% $0.25 ten 4 2 1934, 506 501 1933. During the three nine September 30, 2020 $182,000 $539,000, three nine September 30, 2019 $174,000 $516,000, |
Note 7 - Unsecured Subordinated
Note 7 - Unsecured Subordinated Promissory Notes | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Short-term Debt [Text Block] | NOTE 7 - UNSECURED SUBORDINATED PROMISSORY NOTES The Company had $425,000 September 30, 2020 December 31, 2019. 6% October 15, 2020. three nine September 30, 2020, $6,000 $19,000, three nine September 30, 2019, $4,000 $10,000, $34,000 $15,000 September 30, 2020 December 31, 2019, |
Note 8 - Right to Use Building
Note 8 - Right to Use Building Asset | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Lessee, Operating Leases [Text Block] | NOTE 8 - RIGHT TO USE BUILDING ASSET The FASB issued ASU No. 2016 02, January 1, 2019. January 1, 2019, not no Upon adoption, the Company determined the present value of future lease costs at $257,000, 6% not September 1, 2019, not three nine September 30, 2019 $19,000 $80,000, On August 1, 2019, 350 $212,000. 6% not December 30, 2022. three nine September 30, 2020 $15,000 $46,000, $17,000 2020; $67,000 2021 $67,000 2022. $162,000 $11,000. |
Note 9 - Property and Equipment
Note 9 - Property and Equipment | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Property, Plant and Equipment Disclosure [Text Block] | NOTE 9 At September 30, 2020 December 31, 2019 September 30, 2020 December 31, 2019 Office equipment $ 199,000 $ 199,000 Shop equipment 132,000 132,000 Gross Property and equipment 331,000 331,000 Less accumulated depreciation (302,000 ) (293,000 ) Net property and equipment $ 29,000 $ 38,000 |
Note 10 - Business Segments
Note 10 - Business Segments | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Segment Reporting Disclosure [Text Block] | NOTE 10 - BUSINESS SEGMENTS The Company has two Segment information for the three months ending September 30, 2020 CURA Aegis Corporate Total Revenue $ 2,000 $ - $ - $ 2,000 Gross Profit (Loss) - - - - Total costs and expenses 42,000 5,000 (479,000 ) (432,000 ) Income (Loss) from operations (42,000 ) (5,000 ) 479,000 432,000 Non-operating expense (Income) - (3,000 ) (302,000 ) (305,000 ) Net income (loss) $ (42,000 ) $ (8,000 ) $ 177,000 $ 127,000 Stock based compensation $ 17,000 $ - $ (662,000 ) $ (645,000 ) Depreciation and amortization $ - $ 3,000 $ - $ 3,000 Assets at September 30, 2020 $ - $ 29,000 $ 255,000 $ 284,000 Segment information for the nine months ending September 30, 20 20 for the Company's business segments follows: CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Gross Loss (8,000 ) - - (8,000 ) Total costs and expenses 225,000 57,000 75,000 357,000 (Loss) from operations (233,000 ) (57,000 ) (75,000 ) (365,000 ) Non-operating expense - (3,000 ) (1,079,000 ) (1,082,000 ) Net loss $ (233,000 ) $ (60,000 ) $ (1,154,000 ) $ (1,447,000 ) Stock based compensation $ 57,000 $ (33,000 ) $ (658,000 ) $ (634,000 ) Depreciation and amortization $ - $ 9,000 $ 37,000 $ 46,000 Assets at September 30, 2020 $ - $ 29,000 255,000 $ 284,000 Segment information for the three September 30 , 201 9 for the Company's business segments follows: CURA Aegis Corporate Total Revenue $ 4,000 $ - $ - $ 4,000 Gross profit 2,000 - - 2,000 Total costs and expenses 62,000 127,000 315,000 504,000 Loss from operations (60,000 ) (127,000 ) (315,000 ) (502,000 ) Non-operating expense - - (915,000 ) (915,000 ) Net loss $ (60,000 ) $ (127,000 ) $ (1,230,000 ) $ (1,417,000 ) Stock based compensation $ (12,000 ) $ 0 $ 19,000 $ 7,000 Depreciation and amortization $ 3,000 $ 4,000 $ 30,000 $ 37,000 Assets at September 30, 2019 $ 3,000 $ 40,000 $ 241,000 $ 284,000 Segment information for the nine months ending September 30 , 20 19 for the Company's business segments follows: CURA Aegis Corporate Total Revenue $ 13,000 $ - $ - $ 13,000 Gross profit 2,000 - - 2,000 Total costs and expenses 577,000 446,000 1,017,000 ) 2,040,000 Loss from operations (575,000 ) (446,000 ) (1,017,000 ) (2,038,000 ) Non-operating expense - - (1,492,000 ) (1,492,000 ) Net loss $ (575,000 ) $ (446,000 ) $ (2,509,000 ) $ (3,530,000 ) Stock based compensation $ 2,000 $ 13,000 $ 96,000 $ 111,000 Depreciation and amortization $ 12,000 $ 14,000 $ 83,000 $ 109,000 Assets at September 30, 2019 $ 3,000 $ 40,000 $ 241,000 $ 284,000 |
Note 11 - Preferred and Common
Note 11 - Preferred and Common Stock | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Stockholders' Equity Note Disclosure [Text Block] | NOTE 1 1 - PREFERRED and COMMON STOCK Common Stock We have authorized 400,000,000 $0.01 During the three nine September 30, 2020 0 217,846 2016, 2017 2019 three nine September 30, 2019 33,973 109,125 2016, 2017 2019 Preferred Stock Our certificate of incorporation permits the Company to issue up to 100,000,000 $.01 Class A Preferred Stock At September 30, 2020 December 31, 2019 468,221 8,709 no 459,512 $2,851,000 September 30, 2020 $2,713,000 December 31, 2019. In the event of a liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, Class A Preferred stockholders and Class B stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. The value of the Class A Preferred stockholders' liquidation preference was $2,851,000 $2,713,000 September 30, 2020 December 31, 2019, 1 $4.00 Class B Preferred Stock At September 30, 2020 December 31, 2019, 67,500 $513,000 September 30, 2020 $488,000 December 31, 2019. In the event of liquidation, dissolution and winding up of the Company, and subject to the liquidation rights and privileges of our Class C Preferred stockholders, our Class A Preferred stockholders and our Class B Preferred stockholders have a liquidation preference with respect to all accumulated and unsettled dividends. In the event of a liquidation, dissolution or winding up of the Company, unpaid accumulated dividends on the Class B Preferred are payable in Class B Preferred shares at a rate of one $5.00 Series C Preferred Stock At September 30, 2020 December 31, 2019, 15,687,500 $ 6,275,000 September 30, 2020 December 31, 2019. The Series C Preferred shares have a liquidation preference at their stated value per share of $0.40 The Series C Preferred shares have no no Series C- 2 Preferred Stock At September 30, 2020 December 31, 2019, 24,500,000 2 2 $ 4,900,000 September 30, 2020 December 31, 2019. The Series C- 2 not no 2 may not, two 2 2 2 2 2 2 2 2 not Series C- 3 Preferred Stock At September 30, 2020 December 31, 2019, 3,238,000 3 |
Note 12 - Stock Options
Note 12 - Stock Options | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Share-based Payment Arrangement [Text Block] | NOTE 1 2 - STOCK OPTIONS 2016 Stock Option Plan 2016 “2016 3,000,000 may 2016 September 30, 2020, 342,500 2016 2011 Stock Option Plan 2011 “2011 3,000,000 may 2011 September 30, 2020, 316,000 2011 Under the 2016 2011 may may may not 10% may not 110% ten 10% may not five During the nine September 30, 2020 2,100,000 No nine September 30, 2019. Summary three nine September 30, 2020, $645,000 $634,000, $676,000 third 2020 $782,000 nine September 30, 2020 As of September 30, 2020, $118,000 1 The weighted average grant date fair value of stock options issued during the nine September 30, 2020 $0.15 nine September 30, 2020 September 30, 2019 $88,000 $125,000, The fair value of each option granted was estimated on the date of grant using the Black-Scholes option-pricing model with the following weighted average assumptions: 2020 2019 Expected term (years) 6.3 - Expected forfeiture rate 0 % - Risk-free rate 1.3 % - Volatility 179 % - Dividend yield 0.0 % - The average risk-free interest rate is based on the U.S. treasury security rate in effect as of the grant date. We determined expected volatility using the historical closing stock price. The expected life was generally determined using the simplified method as we do not The following summarizes the activity of our outstanding stock options for the nine September 30, 2020: Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2020 10,740,500 $ 0.50 2.6 $ - Granted 2,100,000 .10 Exercised - - Canceled or expired (6,249,000 ) .40 Outstanding at September 30, 2020 6,591,500 $ 0.47 5.1 $ - Exercisable at September 30, 2020 4,552,000 $ 0.61 3.6 $ - During the nine September 30, 2020, 6,249,000 no nine September 30, 2019, 216,750 no no September 30, 2020, $.07 $1.58 |
Note 13 - Warrants
Note 13 - Warrants | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Stockholders Equity Note Warrants Or Rights [Text Block] | NOTE 1 3 - WARRANTS The following summarizes the activity of our outstanding warrants for the nine September 30, 2020: Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2020 7,731,707 0.45 (A) 6.2 (B) $ 33,000 Granted - - Exercised - - Canceled or expired (100,000 ) 2.50 Outstanding at September 30, 2020 7,631,707 0.42 (A) 5.6 (B) $ 0 Exercisable at September 30, 2020 7,006,707 $ 0.46 5.6 (C) $ 0 (A) The weighted average exercise price for warrants outstanding as of September 30, 2020 2019 1,750,000 no (B) The weighted average remaining contractual term for warrants outstanding as of September 30, 2020 2019 743,500 no (C) The weighted average remaining contractual term for warrants exercisable as of September 30, 2020, 2019 118,500 no |
Note 14 - Related Party Transac
Note 14 - Related Party Transactions | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Related Party Transactions Disclosure [Text Block] | NOTE 1 4 - RELATED PARTY TRANSACTIONS As of September 30, 2020, December 31, 2019, $2,402,000 $2,477,000, 9,338,228 September 30, 2020 9,388,378 December 31, 2019. 1,184,273 1,239,288 September 30, 2020 December 31, 2019. $222,000 $164,000 September 30, 2020 December 31, 2019, As of September 30, 2020 December 31, 2019, $2,070,000 $1,170,000, 10,680,000 September 30, 2020 4,680,000 December 31, 2019. 468,000 September 30, 2020 December 31, 2019. $160,000 $88,000, September 30, 2020 December 31, 2019. As of September 30, 2020 December 31, 2019, $425,000 September 30, 2020, $34,000 6% October 15, 2020. |
Note 15 - Subsequent Events
Note 15 - Subsequent Events | 9 Months Ended |
Sep. 30, 2020 | |
Notes to Financial Statements | |
Subsequent Events [Text Block] | NOTE 1 5 - SUBSEQUENT EVENTS Issuance of Convertible Promissory Note Subsequent to September 30, 2020, $50,000 12 Contingent Liability: Subsequent to September 30, 2020, 1,948,000, September 30, 2020. |
Significant Accounting Policies
Significant Accounting Policies (Policies) | 9 Months Ended |
Sep. 30, 2020 | |
Accounting Policies [Abstract] | |
Basis of Accounting, Policy [Policy Text Block] | Basis of Presentation: 10 8 03 X not not December 31, 2019 2019 10 |
Consolidation, Policy [Policy Text Block] | Consolidation: 56% September 30, 2020, |
Use of Estimates, Policy [Policy Text Block] | Use of Estimates: |
Reclassification, Comparability Adjustment [Policy Text Block] | Reclassifications: may |
Cash and Cash Equivalents, Policy [Policy Text Block] | Cash: may $5,000. |
Inventory, Policy [Policy Text Block] | Inventory September 30, 2020 December 31, 2019 |
Depreciation, Depletion, and Amortization [Policy Text Block] | Depreciation and amortization: three nine September 30, 2020 2019 For the Three Months Ended September 30, For the Nine Months Ended September 30, 2020 2019 2020 2019 Right-to use building $ 17,000 $ 29,000 $ 37,000 $ 81,000 Software amortization - 2,000 - 8,000 Property and equipment 3,000 6,000 9,000 20,000 $ 20,000 $ 37,000 $ 46,000 $ 109,000 |
Lessee, Leases [Policy Text Block] | Right to use building asset: No. 2016 02, January 1, 2019. not no |
Software Property And Equipment [Policy Text Block] | Software, Property and Equipment: 3 5 7 when incurred. When disposed, the cost and accumulated depreciation applicable to assets retired are removed from the accounts and the gain or loss on disposition is recognized in non-operating income (expense). Whenever events or circumstances indicate, our long-lived assets including any intangible assets with finite useful lives are tested for impairment by using the estimated future cash flows directly associated with, and that are expected to arise as a direct result of, the use of the assets. If the carrying amount exceeds the estimated undiscounted cash flows, impairment may |
Fair Value Measurement, Policy [Policy Text Block] | Fair Value of Financial Instruments: , one three Level 1: Level 2: Level 3: not The hierarchy gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1 3 September 30, 2020 December 31, 2019. $2,977,000 September 30, 2020 |
Revenue from Contract with Customer [Policy Text Block] | Revenue Recognition and Deferred Revenue: 606, The Company's revenue is derived primarily from domestic customers. For the three nine September 30, 2020 $2,000 7,000 100% three nine September 30, 2020. 30 CURA revenue is recognized (a) upon receipt of payment at the point of sale of the CURA app, (b) upon the delivery of myCadian products and (c) upon the Company's performance of all obligations as described in customer agreements. The Z-Coach program provides fatigue training over an annual subscription period of twelve |
In Process Research and Development, Policy [Policy Text Block] | Engineering and Development: |
Selling, General and Administrative Expenses, Policy [Policy Text Block] | General and Administrative: three September 30, 2020 2019 $0 $14,000 nine September 30, 2020 2019 $17,000 $35,000 |
Share-based Payment Arrangement [Policy Text Block] | Stock-based Compensation: 718 10 718 10. No |
Income Tax, Policy [Policy Text Block] | Income Taxes: not not We account for uncertain tax positions using a more-likely-than- not not not September 30, 2020, December 31, 2019, no |
Earnings Per Share, Policy [Policy Text Block] | Loss per Common Share: 260 10 September 30, 2020 2019, 107,992,768 104,288,815 625,000 September 30, 2020 2019 not |
Note 2 - Summary of Significa_2
Note 2 - Summary of Significant Accounting Policies (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Depreciation and Amortization [Table Text Block] | For the Three Months Ended September 30, For the Nine Months Ended September 30, 2020 2019 2020 2019 Right-to use building $ 17,000 $ 29,000 $ 37,000 $ 81,000 Software amortization - 2,000 - 8,000 Property and equipment 3,000 6,000 9,000 20,000 $ 20,000 $ 37,000 $ 46,000 $ 109,000 |
Note 3 - Inventory and Vendor_2
Note 3 - Inventory and Vendor Liability (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Schedule of Inventory, Current [Table Text Block] | September 30, 2020 December 31, 2019 Raw materials $ 1,568,000 $ 1,665,000 Finished goods 69,000 69,000 1,637,000 1,734,000 Less: Reserve (1,637,000 ) (1,734,000 ) Inventory (net) $ - $ - Liability for inventory $ 1,740,000 $ 1,764,000 |
Note 6 - Senior Convertible N_2
Note 6 - Senior Convertible Notes (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Convertible Debt [Table Text Block] | Total 2019 6% Notes JULY 2018 Notes 2018 Notes 2017 6% Notes 2016 6% Notes Face value December 31, 2019 $ 10,310,000 $ 650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Notes issued 1,000,000 1,000,000 - - - - Face value September 30, 2020 $ 11,310,000 $ 1,650,000 $ 1,675,000 $ 625,000 $ 4,370,000 $ 2,990,000 Debt discount December 31, 2019 $ (1,901,000 ) $ (3,000 ) $ (354,000 ) $ (185,000 ) $ (362,000 ) $ (997,000 ) Debt discount issued (24,000 ) (24,000 ) - - - - Amortization reported as interest 607,000 21,000 62,000 36,000 83,000 405,000 Debt discount September 30, 2020 $ (1,318,000 ) $ (6,000 ) $ (292,000 ) $ (149,000 ) $ (279,000 ) $ (592,000 ) Senior Convertible Notes (net) $ 9,992,000 $ 1,644,000 $ 1,383,000 $ 476,000 $ 4,091,000 $ 2,398,000 |
Note 9 - Property and Equipme_2
Note 9 - Property and Equipment (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Property, Plant and Equipment [Table Text Block] | September 30, 2020 December 31, 2019 Office equipment $ 199,000 $ 199,000 Shop equipment 132,000 132,000 Gross Property and equipment 331,000 331,000 Less accumulated depreciation (302,000 ) (293,000 ) Net property and equipment $ 29,000 $ 38,000 |
Note 10 - Business Segments (Ta
Note 10 - Business Segments (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Schedule of Segment Reporting Information, by Segment [Table Text Block] | CURA Aegis Corporate Total Revenue $ 2,000 $ - $ - $ 2,000 Gross Profit (Loss) - - - - Total costs and expenses 42,000 5,000 (479,000 ) (432,000 ) Income (Loss) from operations (42,000 ) (5,000 ) 479,000 432,000 Non-operating expense (Income) - (3,000 ) (302,000 ) (305,000 ) Net income (loss) $ (42,000 ) $ (8,000 ) $ 177,000 $ 127,000 Stock based compensation $ 17,000 $ - $ (662,000 ) $ (645,000 ) Depreciation and amortization $ - $ 3,000 $ - $ 3,000 Assets at September 30, 2020 $ - $ 29,000 $ 255,000 $ 284,000 CURA Aegis Corporate Total Revenue $ 7,000 $ - $ - $ 7,000 Gross Loss (8,000 ) - - (8,000 ) Total costs and expenses 225,000 57,000 75,000 357,000 (Loss) from operations (233,000 ) (57,000 ) (75,000 ) (365,000 ) Non-operating expense - (3,000 ) (1,079,000 ) (1,082,000 ) Net loss $ (233,000 ) $ (60,000 ) $ (1,154,000 ) $ (1,447,000 ) Stock based compensation $ 57,000 $ (33,000 ) $ (658,000 ) $ (634,000 ) Depreciation and amortization $ - $ 9,000 $ 37,000 $ 46,000 Assets at September 30, 2020 $ - $ 29,000 255,000 $ 284,000 CURA Aegis Corporate Total Revenue $ 4,000 $ - $ - $ 4,000 Gross profit 2,000 - - 2,000 Total costs and expenses 62,000 127,000 315,000 504,000 Loss from operations (60,000 ) (127,000 ) (315,000 ) (502,000 ) Non-operating expense - - (915,000 ) (915,000 ) Net loss $ (60,000 ) $ (127,000 ) $ (1,230,000 ) $ (1,417,000 ) Stock based compensation $ (12,000 ) $ 0 $ 19,000 $ 7,000 Depreciation and amortization $ 3,000 $ 4,000 $ 30,000 $ 37,000 Assets at September 30, 2019 $ 3,000 $ 40,000 $ 241,000 $ 284,000 CURA Aegis Corporate Total Revenue $ 13,000 $ - $ - $ 13,000 Gross profit 2,000 - - 2,000 Total costs and expenses 577,000 446,000 1,017,000 ) 2,040,000 Loss from operations (575,000 ) (446,000 ) (1,017,000 ) (2,038,000 ) Non-operating expense - - (1,492,000 ) (1,492,000 ) Net loss $ (575,000 ) $ (446,000 ) $ (2,509,000 ) $ (3,530,000 ) Stock based compensation $ 2,000 $ 13,000 $ 96,000 $ 111,000 Depreciation and amortization $ 12,000 $ 14,000 $ 83,000 $ 109,000 Assets at September 30, 2019 $ 3,000 $ 40,000 $ 241,000 $ 284,000 |
Note 12 - Stock Options (Tables
Note 12 - Stock Options (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions [Table Text Block] | 2020 2019 Expected term (years) 6.3 - Expected forfeiture rate 0 % - Risk-free rate 1.3 % - Volatility 179 % - Dividend yield 0.0 % - |
Share-based Payment Arrangement, Option, Activity [Table Text Block] | Weighted Average Average Remaining Aggregate Exercise Contractual Intrinsic Shares Price Term (years) Value Outstanding at January 1, 2020 10,740,500 $ 0.50 2.6 $ - Granted 2,100,000 .10 Exercised - - Canceled or expired (6,249,000 ) .40 Outstanding at September 30, 2020 6,591,500 $ 0.47 5.1 $ - Exercisable at September 30, 2020 4,552,000 $ 0.61 3.6 $ - |
Note 13 - Warrants (Tables)
Note 13 - Warrants (Tables) | 9 Months Ended |
Sep. 30, 2020 | |
Notes Tables | |
Schedule of Stockholders' Equity Note, Warrants or Rights [Table Text Block] | Shares Weighted Average Exercise Price Weighted Average Remaining Contractual Term Aggregate Intrinsic Value Outstanding at January 1, 2020 7,731,707 0.45 (A) 6.2 (B) $ 33,000 Granted - - Exercised - - Canceled or expired (100,000 ) 2.50 Outstanding at September 30, 2020 7,631,707 0.42 (A) 5.6 (B) $ 0 Exercisable at September 30, 2020 7,006,707 $ 0.46 5.6 (C) $ 0 |
Note 1 - The Company and Basi_2
Note 1 - The Company and Basis of Presentation (Details Textual) | 9 Months Ended | |||||||
Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Jun. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Dec. 31, 2019USD ($) | Jun. 30, 2019USD ($) | Mar. 31, 2019USD ($) | Dec. 31, 2018USD ($) | |
Number of Operating Segments | 2 | |||||||
Cash and Cash Equivalents, at Carrying Value, Ending Balance | $ 87,000 | $ 18,000 | ||||||
Working Capital | (4,104,000) | |||||||
Retained Earnings (Accumulated Deficit), Ending Balance | (92,872,000) | (91,425,000) | ||||||
Stockholders' Equity Attributable to Parent, Ending Balance | (14,222,000) | $ (11,520,000) | $ (13,708,000) | $ (12,890,000) | $ (12,203,000) | $ (10,393,000) | $ (9,497,000) | $ (8,479,000) |
Proceeds From Convertible Debt, Gross | 1,000,000 | |||||||
Proceeds from Issuance of Unsecured Debt | 228,000 | |||||||
Minimum [Member] | ||||||||
Cash Needed During the Year to Fund Current and Future Commitments | 1,700,000 | |||||||
Maximum [Member] | ||||||||
Cash Needed During the Year to Fund Current and Future Commitments | 2,000,000 | |||||||
Paycheck Protection Program and US Small Business Association Economic Injury Disaster Loan Grant [Member] | ||||||||
Proceeds from Issuance of Unsecured Debt | $ 235,000 |
Note 2 - Summary of Significa_3
Note 2 - Summary of Significant Accounting Policies (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Revenue from Contract with Customer, Including Assessed Tax | $ 2,000 | $ 4,000 | $ 7,000 | $ 13,000 |
Patent Cost | 0 | $ 14,000 | 17,000 | $ 35,000 |
Excess Tax Benefit from Share-based Compensation, Operating Activities | 0 | |||
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued, Total | $ 0 | $ 0 | ||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 107,992,768 | 104,288,815 | ||
Warrant [Member] | ||||
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount (in shares) | 625,000 | |||
Z-Coach Aviation Wellness Program Annual Subscription [Member] | ||||
Deferred Revenue Arrangement, Subscription Period (Month) | 1 year | |||
Revenue Benchmark [Member] | Customer Concentration Risk [Member] | Customer One [Member] | ||||
Concentration Risk, Percentage | 100.00% | |||
Transferred over Time [Member] | ||||
Revenue from Contract with Customer, Including Assessed Tax | $ 2,000 | $ 7,000 | ||
Senior Convertible Promissory Notes [Member] | ||||
Long-term Debt, Fair Value | 2,977,000 | $ 2,977,000 | ||
Minimum [Member] | ||||
Property, Plant and Equipment, Useful Life (Year) | 5 years | |||
Maximum [Member] | ||||
Property, Plant and Equipment, Useful Life (Year) | 7 years | |||
Computer Software, Intangible Asset [Member] | ||||
Finite-Lived Intangible Asset, Useful Life (Year) | 3 years | |||
Commercial Paper [Member] | Collateral Pledged [Member] | ||||
Debt Instrument, Collateral Amount | $ 5,000 | $ 5,000 | ||
Subsidiaries [Member] | ||||
Equity Method Investment, Ownership Percentage | 56.00% | 56.00% |
Note 2 - Summary of Significa_4
Note 2 - Summary of Significant Accounting Policies - Depreciation and Amortization (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Depreciation and amortization | $ 3,000 | $ 37,000 | $ 46,000 | $ 109,000 |
Right-to-use Building [Member] | ||||
Depreciation and amortization | 17,000 | 29,000 | 37,000 | 81,000 |
Software Development [Member] | ||||
Depreciation and amortization | 2,000 | 8,000 | ||
Property and Equipment [Member] | ||||
Depreciation and amortization | $ 3,000 | $ 6,000 | $ 9,000 | $ 20,000 |
Note 3 - Inventory and Vendor_3
Note 3 - Inventory and Vendor Liability (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | |
Inventory (Recovery) Write-down | $ (74,000) | $ (13,000) | $ (97,000) | $ (13,000) |
Note 3 - Inventory and Vendor_4
Note 3 - Inventory and Vendor Liability - Inventory (Details) - USD ($) | Sep. 30, 2020 | Dec. 31, 2019 |
Raw materials | $ 1,568,000 | $ 1,665,000 |
Finished goods | 69,000 | 69,000 |
Inventory, Gross, Total | 1,637,000 | 1,734,000 |
Less: Reserve | (1,637,000) | (1,734,000) |
Inventory (net) | ||
Liability for inventory | $ 1,740,000 | $ 1,764,000 |
Note 4 - Demand Note (Details T
Note 4 - Demand Note (Details Textual) | Jul. 23, 2019USD ($)$ / shares | Sep. 30, 2020USD ($)$ / sharesshares | Jun. 30, 2020USD ($) | Mar. 31, 2020USD ($) | Jun. 30, 2019USD ($) | Sep. 30, 2020USD ($)$ / sharesshares | Sep. 30, 2019USD ($) | Dec. 31, 2019USD ($) |
Long-term Debt, Gross | $ 11,310,000 | $ 11,310,000 | $ 10,310,000 | |||||
Stock Issued During Period, Value, New Issues | 4,000 | $ 10,000 | $ 10,000 | $ 12,000 | ||||
Credit Facility with Co-borrowers [Member] | ||||||||
Line of Credit Facility, Maximum Borrowing Capacity | $ 1,500,000 | |||||||
Debt Instrument, Convertible, Number of Equity Instruments | 30,000 | |||||||
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments | $ 100,000 | |||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.15 | |||||||
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division (Day) | 5 days | |||||||
Long-term Debt, Gross | 650,000 | $ 650,000 | ||||||
Stock Issued in Connection with Debt Issuance, Shares (in shares) | shares | 195,000 | |||||||
Stock Issued During Period, Value, New Issues | $ 21,000 | |||||||
Interest Expense, Debt, Total | $ 5,000 | $ 19,000 | $ 12,000 | |||||
Credit Facility with Co-borrowers [Member] | Prime Rate [Member] | ||||||||
Long-term Debt, Percentage Bearing Variable Interest, Percentage Rate | 3.25% | 3.25% | ||||||
Credit Facility with Co-borrowers [Member] | Rights Related to Credit Facility with Co-borrowers [Member] | ||||||||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 4,333,333 | 4,333,333 | ||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.15 | $ 0.15 | ||||||
Warrants and Rights Outstanding | $ 276,000 | $ 276,000 |
Note 5 - Paycheck Protection _2
Note 5 - Paycheck Protection Plan Loan (Details Textual) - USD ($) | 9 Months Ended | |
Sep. 30, 2020 | Sep. 30, 2019 | |
Proceeds from Issuance of Unsecured Debt | $ 228,000 | |
Paycheck Protection Program CARES Act [Member] | ||
Proceeds from Issuance of Unsecured Debt | $ 228,000 |
Note 6 - Senior Convertible N_3
Note 6 - Senior Convertible Notes (Details Textual) | Jul. 24, 2018USD ($)$ / shares | May 08, 2018USD ($)$ / shares | Aug. 25, 2016USD ($)$ / shares | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Sep. 30, 2020USD ($) | Sep. 30, 2019USD ($) | Dec. 31, 2019USD ($)$ / shares | Dec. 31, 2017USD ($)$ / shares | Apr. 30, 2019USD ($) | Nov. 30, 2018$ / shares |
Long-term Debt, Gross | $ 11,310,000 | $ 11,310,000 | $ 10,310,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 1,318,000 | 1,318,000 | 1,901,000 | ||||||||
Proceeds from Convertible Debt | 1,000,000 | ||||||||||
Increase in Unamortized Debt Discount Due to Issuance | 24,000 | ||||||||||
Warrants Related to the 2017 Convertible Notes [Member] | |||||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.333 | ||||||||||
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes | 25.00% | ||||||||||
Warrants Related to the 2016 Convertible Notes [Member] | |||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Warrants and Rights Outstanding, Term (Year) | 10 years | ||||||||||
Percentage of Shares Issuable Upon the Conversion of the Promissory Notes | 10.00% | ||||||||||
Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 11,310,000 | 11,310,000 | 10,310,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 1,318,000 | 1,318,000 | 1,901,000 | ||||||||
Long-term Debt, Total | 9,992,000 | 9,992,000 | 8,409,000 | ||||||||
Long-Term Debt, Maturity, Year One | 2,990,000 | 2,990,000 | |||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Two | 2,775,000 | 2,775,000 | |||||||||
Long-term Debt, Maturities, Repayments of Principal in Year Three | 3,395,000 | 3,395,000 | |||||||||
Long-Term Debt, Maturity, Year Four | 1,150,000 | 1,150,000 | |||||||||
Long-Term Debt, Maturities Repayments of Principal, After Year Four | 1,000,000 | 1,000,000 | |||||||||
Convertible Notes [Member] | Investor [Member] | |||||||||||
Long-term Debt, Total | 2,402,000 | 2,402,000 | 2,477,000 | ||||||||
Convertible Notes [Member] | Affiliated Entity [Member] | |||||||||||
Long-term Debt, Total | 2,070,000 | $ 2,070,000 | $ 1,170,000 | ||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 10,680,000 | 4,680,000 | |||||||||
The 2019 Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 1,650,000 | $ 1,650,000 | $ 650,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 6,000 | 6,000 | $ 3,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 2,500,000 | ||||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||||||||
Debt Instrument, Term, Number of Days after Substantial Sale of Aegis Division (Day) | 5 days | ||||||||||
Debt Instrument, Term (Year) | 5 years | ||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.15 | ||||||||||
Debt Instrument, Convertible, Number of Equity Instruments | 30,000 | ||||||||||
Debt Instrument, Convertible, Threshold Amount Needed to Invest to Convert a Specified Number of Equity Instruments | $ 100,000 | ||||||||||
Proceeds from Convertible Debt | 275,000 | 1,000,000 | |||||||||
Increase in Unamortized Debt Discount Due to Issuance | 5,000 | 24,000 | |||||||||
Interest Expense, Debt, Total | 32,000 | $ 15,000 | 78,000 | $ 19,000 | |||||||
July 2018 Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 1,675,000 | 1,675,000 | 1,675,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 292,000 | 292,000 | 354,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 2,500,000 | ||||||||||
Debt Instrument, Term (Year) | 5 years | ||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Proceeds from Convertible Debt | |||||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||||
Interest Expense, Debt, Total | 21,000 | 20,000 | 62,000 | 52,000 | |||||||
Warrants Related to July 2018 Convertible Notes [Member] | |||||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold | 25.00% | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Warrants and Rights Outstanding, Term (Year) | 10 years | ||||||||||
The 2018 Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 625,000 | 625,000 | 625,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 149,000 | 149,000 | 185,000 | ||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 1,000,000 | ||||||||||
Debt Instrument, Term (Year) | 5 years | ||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Proceeds from Convertible Debt | |||||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||||
Interest Expense, Debt, Total | 12,000 | 11,000 | 36,000 | 34,000 | |||||||
Warrants Related to the 2018 Convertible Notes [Member] | |||||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Below Investment Threshold | 10.00% | ||||||||||
Percentage of Shares Issuable Upon Conversion of the Promissory Notes, Above Investment Threshold | 25.00% | ||||||||||
Class of Warrant or Right, Exercise Price of Warrants or Rights (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Warrants and Rights Outstanding, Term (Year) | 10 years | ||||||||||
The 2017 Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 4,370,000 | 4,370,000 | 4,370,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 279,000 | 279,000 | 362,000 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||||||||
Debt Instrument, Term (Year) | 5 years | ||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.50 | $ 0.333 | |||||||||
Proceeds from Convertible Debt | |||||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||||
Interest Expense, Debt, Total | 94,000 | 92,000 | 279,000 | 264,000 | |||||||
The 2017 Convertible Notes [Member] | Maximum [Member] | |||||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 5,000,000 | ||||||||||
The 2016 Convertible Notes [Member] | |||||||||||
Long-term Debt, Gross | 2,990,000 | 2,990,000 | 2,990,000 | ||||||||
Debt Instrument, Unamortized Discount, Total | 592,000 | 592,000 | $ 997,000 | ||||||||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | ||||||||||
Debt Instrument, Term (Year) | 5 years | ||||||||||
Debt Instrument, Convertible, Conversion Price (in dollars per share) | $ / shares | $ 0.25 | ||||||||||
Proceeds from Convertible Debt | |||||||||||
Increase in Unamortized Debt Discount Due to Issuance | |||||||||||
Interest Expense, Debt, Total | $ 182,000 | $ 174,000 | $ 539,000 | $ 516,000 | |||||||
The 2016 Convertible Notes [Member] | Maximum [Member] | |||||||||||
Amount of Senior Convertible Promissory Notes Authorized to Issue in Private Placement | $ 3,000,000 |
Note 6 - Senior Convertible N_4
Note 6 - Senior Convertible Notes - Schedule of Senior Convertible Notes Outstanding (Details) - USD ($) | 3 Months Ended | 9 Months Ended | ||
Sep. 30, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Face value | $ 10,310,000 | |||
Notes issued | 1,000,000 | |||
Face value | $ 11,310,000 | 11,310,000 | ||
Debt discount | (1,901,000) | |||
Debt discount issued | (24,000) | |||
Amortization reported as interest | 607,000 | $ 546,000 | ||
Debt discount | (1,318,000) | (1,318,000) | ||
Senior Convertible Notes (net) | 9,992,000 | 9,992,000 | $ 8,410,000 | |
The 2019 Convertible Notes [Member] | ||||
Face value | 650,000 | |||
Notes issued | 275,000 | 1,000,000 | ||
Face value | 1,650,000 | 1,650,000 | ||
Debt discount | (3,000) | |||
Debt discount issued | (5,000) | (24,000) | ||
Amortization reported as interest | 21,000 | |||
Debt discount | (6,000) | (6,000) | ||
Senior Convertible Notes (net) | 1,644,000 | 1,644,000 | ||
July 2018 Convertible Notes [Member] | ||||
Face value | 1,675,000 | |||
Notes issued | ||||
Face value | 1,675,000 | 1,675,000 | ||
Debt discount | (354,000) | |||
Debt discount issued | ||||
Amortization reported as interest | 62,000 | |||
Debt discount | (292,000) | (292,000) | ||
Senior Convertible Notes (net) | 1,383,000 | 1,383,000 | ||
The 2018 Convertible Notes [Member] | ||||
Face value | 625,000 | |||
Notes issued | ||||
Face value | 625,000 | 625,000 | ||
Debt discount | (185,000) | |||
Debt discount issued | ||||
Amortization reported as interest | 36,000 | |||
Debt discount | (149,000) | (149,000) | ||
Senior Convertible Notes (net) | 476,000 | 476,000 | ||
The 2017 Convertible Notes [Member] | ||||
Face value | 4,370,000 | |||
Notes issued | ||||
Face value | 4,370,000 | 4,370,000 | ||
Debt discount | (362,000) | |||
Debt discount issued | ||||
Amortization reported as interest | 83,000 | |||
Debt discount | (279,000) | (279,000) | ||
Senior Convertible Notes (net) | 4,091,000 | 4,091,000 | ||
The 2016 Convertible Notes [Member] | ||||
Face value | 2,990,000 | |||
Notes issued | ||||
Face value | 2,990,000 | 2,990,000 | ||
Debt discount | (997,000) | |||
Debt discount issued | ||||
Amortization reported as interest | 405,000 | |||
Debt discount | (592,000) | (592,000) | ||
Senior Convertible Notes (net) | $ 2,398,000 | $ 2,398,000 |
Note 7 - Unsecured Subordinat_2
Note 7 - Unsecured Subordinated Promissory Notes (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Short-term Debt, Total | $ 425,000 | $ 425,000 | $ 425,000 | ||
Unsecured Subordinated Promissory Notes [Member] | |||||
Short-term Debt, Total | $ 425,000 | $ 425,000 | 425,000 | ||
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | 6.00% | |||
Interest Expense, Debt, Total | $ 6,000 | $ 4,000 | $ 19,000 | $ 10,000 | |
Interest Payable | $ 34,000 | $ 34,000 | $ 15,000 |
Note 8 - Right to Use Buildin_2
Note 8 - Right to Use Building Asset (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | ||||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | Aug. 01, 2019 | |
Office Building with Terminated Lease Obligation [Member] | ||||||
Operating Lease, Liability, Total | $ 257,000 | $ 257,000 | ||||
Lessee, Operating Lease, Discount Rate | 6.00% | |||||
Operating Lease, Cost | $ 19,000 | $ 80,000 | ||||
Office Located in 350 Linden Oaks in Rochester New York [Member] | ||||||
Operating Lease, Liability, Total | $ 212,000 | |||||
Lessee, Operating Lease, Discount Rate | 6.00% | |||||
Operating Lease, Cost | 15,000 | 46,000 | ||||
Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | 17,000 | 17,000 | ||||
Lessee, Operating Lease, Liability, to be Paid, Year One | 67,000 | 67,000 | ||||
Lessee, Operating Lease, Liability, to be Paid, Year Two | 67,000 | 67,000 | ||||
Lessee, Operating Lease, Liability, to be Paid, Total | 162,000 | 162,000 | ||||
Lessee, Operating Lease, Liability, Undiscounted Excess Amount | $ 11,000 | $ 11,000 |
Note 9 - Property and Equipme_3
Note 9 - Property and Equipment - Property and Equipment (Details) - USD ($) | Sep. 30, 2020 | Dec. 31, 2019 |
Office equipment | $ 199,000 | $ 199,000 |
Shop equipment | 132,000 | 132,000 |
Gross Property and equipment | 331,000 | 331,000 |
Less accumulated depreciation | (302,000) | (293,000) |
Net property and equipment | $ 29,000 | $ 38,000 |
Note 10 - Business Segments (De
Note 10 - Business Segments (Details Textual) | 9 Months Ended |
Sep. 30, 2020 | |
Number of Operating Segments | 2 |
Note 10 - Business Segments - O
Note 10 - Business Segments - Operation by Segments (Details) - USD ($) | 3 Months Ended | 9 Months Ended | |||||||
Sep. 30, 2020 | Jun. 30, 2020 | Mar. 31, 2020 | Sep. 30, 2019 | Jun. 30, 2019 | Mar. 31, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Revenue | $ 2,000 | $ 4,000 | $ 7,000 | $ 13,000 | |||||
Gross Profit (Loss) | 2,000 | (8,000) | 2,000 | ||||||
Total costs and expenses | (432,000) | 504,000 | 357,000 | 2,040,000 | |||||
Income (Loss) from operations | 432,000 | (502,000) | (365,000) | (2,038,000) | |||||
Non-operating expense (Income) | (305,000) | (915,000) | (1,082,000) | (1,492,000) | |||||
Net loss | 127,000 | $ (821,000) | $ (753,000) | (1,417,000) | $ (965,000) | $ (1,148,000) | (1,447,000) | (3,530,000) | |
Stock based compensation | (645,000) | 7,000 | (634,000) | 111,000 | |||||
Depreciation and amortization | 3,000 | 37,000 | 46,000 | 109,000 | |||||
Assets | 284,000 | 284,000 | 284,000 | 284,000 | $ 251,000 | ||||
Operating Segments [Member] | CURA Division [Member] | |||||||||
Revenue | 2,000 | 4,000 | 7,000 | 13,000 | |||||
Gross Profit (Loss) | 2,000 | (8,000) | 2,000 | ||||||
Total costs and expenses | 42,000 | 62,000 | 225,000 | 577,000 | |||||
Income (Loss) from operations | (42,000) | (60,000) | (233,000) | (575,000) | |||||
Non-operating expense (Income) | |||||||||
Net loss | (42,000) | (60,000) | (233,000) | (575,000) | |||||
Stock based compensation | 17,000 | (12,000) | 57,000 | 2,000 | |||||
Depreciation and amortization | 3,000 | 12,000 | |||||||
Assets | 3,000 | 3,000 | |||||||
Operating Segments [Member] | Aegis Division [Member] | |||||||||
Revenue | |||||||||
Gross Profit (Loss) | |||||||||
Total costs and expenses | 5,000 | 127,000 | 57,000 | 446,000 | |||||
Income (Loss) from operations | (5,000) | (127,000) | (57,000) | (446,000) | |||||
Non-operating expense (Income) | (3,000) | (3,000) | |||||||
Net loss | (8,000) | (127,000) | (60,000) | (446,000) | |||||
Stock based compensation | 0 | (33,000) | 13,000 | ||||||
Depreciation and amortization | 3,000 | 4,000 | 9,000 | 14,000 | |||||
Assets | 29,000 | 40,000 | 29,000 | 40,000 | |||||
Corporate, Non-Segment [Member] | |||||||||
Revenue | |||||||||
Gross Profit (Loss) | |||||||||
Total costs and expenses | (479,000) | 315,000 | 75,000 | 1,017,000 | |||||
Income (Loss) from operations | 479,000 | (315,000) | (75,000) | (1,017,000) | |||||
Non-operating expense (Income) | (302,000) | (915,000) | (1,079,000) | (1,492,000) | |||||
Net loss | 177,000 | (1,230,000) | (1,154,000) | (2,509,000) | |||||
Stock based compensation | (662,000) | 19,000 | (658,000) | 96,000 | |||||
Depreciation and amortization | 30,000 | 37,000 | 83,000 | ||||||
Assets | $ 255,000 | $ 241,000 | $ 255,000 | $ 241,000 |
Note 11 - Preferred and Commo_2
Note 11 - Preferred and Common Stock (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2019 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Common stock, shares authorized (in shares) | 400,000,000 | 400,000,000 | 400,000,000 | ||
Common stock, par value (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||
Preferred stock, shares authorized (in shares) | 100,000,000 | 100,000,000 | 100,000,000 | ||
Preferred Stock, Par or Stated Value Per Share (in dollars per share) | $ 0.01 | $ 0.01 | $ 0.01 | ||
Preferred Class A [Member] | |||||
Preferred stock, shares outstanding (in shares) | 468,221 | 468,221 | 468,221 | ||
Preferred Stock, Shares Outstanding, Not Accruing Dividends (in shares) | 8,709 | 8,709 | 8,709 | ||
Preferred Stock, Shares Outstanding, Accruing Dividends (in shares) | 459,512 | 459,512 | |||
Dividends Payable | $ 2,851,000 | $ 2,851,000 | $ 2,713,000 | ||
Preferred Stock, Liquidation Preference, Value | $ 2,851,000 | $ 2,851,000 | $ 2,713,000 | ||
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ 4 | $ 4 | |||
Preferred Class B [Member] | |||||
Preferred stock, shares outstanding (in shares) | 67,500 | 67,500 | 67,500 | ||
Dividends Payable | $ 513,000 | $ 513,000 | $ 488,000 | ||
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ 5 | $ 5 | |||
Series C Preferred Stock [Member] | |||||
Preferred stock, shares outstanding (in shares) | 15,687,500 | 15,687,500 | 15,687,500 | ||
Preferred Stock, Liquidation Preference, Value | $ 6,275,000 | $ 6,275,000 | $ 6,275,000 | ||
Preferred Stock, Liquidation Preference Per Share (in dollars per share) | $ 0.40 | $ 0.40 | |||
Series C2 Preferred Stock [Member] | |||||
Preferred stock, shares outstanding (in shares) | 24,500,000 | 24,500,000 | 24,500,000 | ||
Preferred Stock, Liquidation Preference, Value | $ 4,900,000 | $ 4,900,000 | $ 4,900,000 | ||
Series C3 Preferred Stock [Member] | |||||
Preferred stock, shares outstanding (in shares) | 3,238,000 | 3,238,000 | 3,238,000 | ||
The 2016, 2017 and 2019 Convertible Notes [Member] | |||||
Stock Issued During Period, Shares, Interest (in shares) | 0 | 33,973 | 217,846 | 109,125 |
Note 12 - Stock Options (Detail
Note 12 - Stock Options (Details Textual) - USD ($) | 3 Months Ended | 9 Months Ended | |||
Sep. 30, 2020 | Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2016 | Dec. 31, 2011 | |
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | 2,100,000 | ||||
Reversal of Allocated Share-based Compensation Expense | $ 645,000 | $ 634,000 | |||
Increase (Decrease) in Allocated Share-based Compensation Expense, Forefitures | 676,000 | 782,000 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount, Total | $ 118,000 | $ 118,000 | |||
Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition (Year) | 1 year | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value (in dollars per share) | $ 0.15 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value | $ 88,000 | $ 125,000 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period (in shares) | 6,249,000 | 216,750 | |||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period (in shares) | 0 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period (in shares) | 0 | ||||
Share-based Payment Arrangement, Option, Exercise Price Range, Lower Range Limit (in dollars per share) | $ 0.07 | ||||
Share-based Payment Arrangement, Option, Exercise Price Range, Upper Range Limit (in dollars per share) | $ 1.58 | ||||
Stock Option Plan 2016 [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) | 3,000,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 342,500 | 342,500 | |||
Stock Option Plan 2011 [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized (in shares) | 3,000,000 | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Available for Grant (in shares) | 316,000 | 316,000 | |||
Stock Option Plan 2011 and 2016 [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Percentage of Outstanding Stock Maximum | 10.00% | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Expiration Period (Year) | 10 years | ||||
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross (in shares) | 2,100,000 | 0 | |||
Stock Option Plan 2011 and 2016 [Member] | Minimum [Member] | |||||
Share-based Compensation Arrangement by Share-based Payment Award, Discount from Market Price, Offering Date | 110.00% |
Note 12 - Stock Options - Stock
Note 12 - Stock Options - Stock Options Valuation Assumptions (Details) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2020 | Dec. 31, 2019 | |
Expected term (years) (Year) | 6 years 109 days | |
Expected forfeiture rate | 0.00% | |
Risk-free rate | 1.30% | |
Volatility | 179.00% | |
Dividend yield | 0.00% |
Note 12 - Stock Options - Share
Note 12 - Stock Options - Share-based Compensation, Stock Options, Activity (Details) - USD ($) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Sep. 30, 2019 | Dec. 31, 2019 | |
Outstanding shares (in shares) | 10,740,500 | ||
Outstanding - weighted average exercise price (in dollars per share) | $ 0.50 | ||
Outstanding - weighted average remaining contractual term (Year) | 5 years 36 days | 2 years 219 days | |
Outstanding - aggregate intrinsic value | |||
Shares, granted (in shares) | 2,100,000 | ||
Weighted average exercise price, granted (in dollars per share) | $ 0.10 | ||
Shares, exercised (in shares) | 0 | ||
Weighted average exercise price, exercised (in dollars per share) | |||
Shares, canceled or expired (in shares) | (6,249,000) | ||
Weighted average exercise price, canceled or expired (in dollars per share) | $ 0.40 | ||
Outstanding shares (in shares) | 6,591,500 | 10,740,500 | |
outstanding - weighted average exercise price (in dollars per share) | $ 0.47 | $ 0.50 | |
Shares, exercisable (in shares) | 4,552,000 | ||
Weighted average exercise price, exercisable (in dollars per share) | $ 0.61 | ||
Exercisable- weighted average remaining contractual term (Year) | 3 years 219 days | ||
Exercisable-aggregate intrinsic value |
Note 13 - Warrants (Details Tex
Note 13 - Warrants (Details Textual) - shares | Sep. 30, 2020 | Dec. 31, 2019 | Sep. 30, 2019 |
Class of Warrant or Right, Outstanding (in shares) | 7,631,707 | 7,731,707 | |
Warrants without Expiration Date, Outstanding (in shares) | 743,500 | 743,500 | |
Warrants without Expiration Date, Exercisable (in shares) | 118,500 | 118,500 | |
Warrants Not Determined, Exercise Price [Member] | |||
Class of Warrant or Right, Outstanding (in shares) | 1,750,000 | 1,750,000 |
Note 13 - Warrants - Summary of
Note 13 - Warrants - Summary of Outstanding Warrants (Details) - USD ($) | 9 Months Ended | 12 Months Ended | |
Sep. 30, 2020 | Dec. 31, 2019 | ||
Shares outstanding (in shares) | 7,731,707 | ||
Outstanding, weighted average exercise price (in dollars per share) | [1] | $ 0.45 | |
Outstanding, weighted average remaining contractual term (Year) | [2] | 5 years 219 days | 6 years 73 days |
Outstanding, aggregate intrinsic value | $ 0 | $ 33,000 | |
Shares granted (in shares) | |||
Granted, weighted average exercise price (in dollars per share) | |||
Shares exercised (in shares) | |||
Exercised, weighted average exercise price (in dollars per share) | |||
Shares canceled or expired (in shares) | (100,000) | ||
Canceled or expired, weighted average exercise price (in dollars per share) | $ 2.50 | ||
Shares outstanding (in shares) | 7,631,707 | 7,731,707 | |
Outstanding, weighted average exercise price (in dollars per share) | [1] | $ 0.42 | $ 0.45 |
Shares exercisable (in shares) | 7,006,707 | ||
Exercisable, weighted average exercise price (in dollars per share) | $ 0.46 | ||
Exercisable, weighted average remaining contractual term (Year) | [3] | 5 years 219 days | |
Exercisable, aggregate intrinsic value | $ 0 | ||
[1] | The weighted average exercise price for warrants outstanding as of September 30, 2020 and 2019 excludes 1,750,000 warrants in each period with no determined exercise price. | ||
[2] | The weighted average remaining contractual term for warrants outstanding as of September 30, 2020 and 2019 excludes 743,500 warrants with no expiration date. | ||
[3] | The weighted average remaining contractual term for warrants exercisable as of September 30, 2020, and 2019 excludes 118,500 warrants with no expiration date. |
Note 14 - Related Party Trans_2
Note 14 - Related Party Transactions (Details Textual) | 9 Months Ended | 12 Months Ended |
Sep. 30, 2020USD ($)shares | Dec. 31, 2019USD ($)shares | |
Short-term Debt, Total | $ 425,000 | $ 425,000 |
Unsecured Subordinated Promissory Notes [Member] | ||
Interest Payable | 34,000 | 15,000 |
Short-term Debt, Total | $ 425,000 | $ 425,000 |
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | |
Unsecured Subordinated Promissory Notes [Member] | ||
Interest Payable | $ 34,000 | |
Debt Instrument, Interest Rate, Stated Percentage | 6.00% | |
Various Members of the Board of Directors [Member] | Warrants Related to the Convertible Notes [Member] | ||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 1,184,273 | 1,239,288 |
Interest Payable | $ 222,000 | $ 164,000 |
Various Members of the Board of Directors [Member] | Convertible Notes [Member] | ||
Notes Payable, Related Parties | $ 2,402,000 | $ 2,477,000 |
Debt Instrument, Convertible, Number of Equity Instruments | 9,338,228 | 9,388,378 |
Affiliated Entity [Member] | Warrants Related to the Convertible Notes [Member] | ||
Class of Warrant or Right, Number of Securities Called by Warrants or Rights (in shares) | shares | 468,000 | 468,000 |
Interest Payable | $ 160,000 | $ 88,000 |
Affiliated Entity [Member] | Convertible Notes [Member] | ||
Notes Payable, Related Parties | $ 2,070,000 | $ 1,170,000 |
Debt Instrument, Convertible, Number of Equity Instruments | 10,680,000 | 4,680,000 |
Note 15 - Subsequent Events (De
Note 15 - Subsequent Events (Details Textual) - USD ($) | Oct. 01, 2020 | Sep. 30, 2020 |
Proceeds from Convertible Debt | $ 1,000,000 | |
Subsequent Event [Member] | ||
Proceeds from Convertible Debt | $ 50,000 | |
Contractual Obligation, Total | $ 1,948,000 |